|
|
 |
|
Viewing report
|
|
|
|
China Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Global Markets Direct, Dec 2008, Pages: 118
1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered in the Report 14
3.1 Neurology Devices 14
3.2 CSF (Cerebro Spinal Fluid) Management 14
3.2.1 Hydrocephalus shunt 14
3.2.2 Intra Cranial Pressure (ICP) Monitors 14
3.3 Interventional Neurology 14
3.3.1 Aneurysm Clips 14
3.3.2 Embolic System 14
3.3.3 Navigational System 15
3.4 Neurostimulation Device 15
3.4.1 Spinal Cord Stimulator (SCS) 15
3.4.2 Deep Brain Stimulator (DBS) 15
3.4.3 Vagus Nerve stimulation (VNS) 15
3.5 Neurosurgical Products (Neuroendoscopes) 16
3.5.1 Neurosurgical Products (Neuroendoscopes) 16
3.6 Radio surgery 16
3.6.1 Cyber Knife Radiosurgery 16
3.6.2 Gamma Knife Radiosurgery 16
4 Healthcare Sector Review 17
4.1 Healthcare Expenditure 17
4.2 Healthcare Infrastructure 18
4.2.1 Healthcare Personnel Data 19
4.2.2 Healthcare Facilities Data 20
4.3 Healthcare Policy 23
4.4 China Healthcare Trade Statistics 24
5 Regulation System 25
5.1 Medical Equipment Approval Process 25
5.1.1 Classification 25
5.1.2 Registration and Conformity assessment 26
5.1.3 China Compulsory Certificate (CCC Mark) 28
5.1.4 Labeling and Packaging 29
5.1.5 Registration Fee 30
5.1.6 Registration Period 30
5.2 Post Market Surveillance (PMS) 30
6 Pricing and Reimbursement 31
7 Distribution Structure 33
8 Neurology Devices In China 34
8.1 Neurology Devices Cross Country Comparison (2000-2012) 34
8.2 Neurology Devices, China, Overall Revenues ($ mn), 2000-2012 35
8.3 Neurology Devices, China, Category Volume (Units), 2000-2012 39
8.4 Neurology Devices, China Company share (2006-2007) 41
9 CSF Management In China 42
9.1 CSF Management Overall Revenue (2000-2012) 42
9.2 CSF Management Overall Volume (2000-2012) 44
9.3 CSF Management Average Price (2000-2012) 46
9.4 CSF Management Distribution Share (2006-2007) 47
9.5 CSF Management, China, Company Share (2006-2007) 48
10 Interventional Neurology In China 49
10.1 Interventional Neurology Overall Revenue (2000-2012) 49
10.1.1 Embolic Systems Revenue (2000-2012) 51
10.1.2 Navigational Systems Revenue (2000-2012) 53
10.2 Interventional Neurology Overall Volume (2000-2012) 55
10.2.1 Embolic Systems Volume (2000-2012) 57
10.2.2 Navigational Systems Volume (2000-2012) 59
10.3 Interventional Neurology Average Price (2000-2012) 61
10.4 Interventional Neurology Distribution Share (2006-2007) 62
10.5 Interventional Neurology, China, Company Share (2006-2007) 63
11 Neurostimulation Devices In China 64
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 64
11.2 Neurostimulation Devices Overall Volume (2000-2012) 66
11.3 Neurostimulation Devices Average Price (2000-2012) 68
11.4 Neurostimulation Devices Distribution Share (2006-2007) 69
11.5 Neurostimulation Devices, China, Company Share (2006-2007) 70
12 Neurosurgical Products (Neuroendoscopes) In China 71
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 71
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 73
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 75
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 75
12.5 Neurosurgical Products (Neuroendoscopes), China, Company Share (2006-2007) 76
13 Radiosurgery In China 77
13.1 Radiosurgery Overall Revenue (2000-2012) 77
13.2 Radiosurgery Overall Volume (2000-2012) 79
13.3 Radiosurgery Average Price (2000-2012) 81
13.4 Radiosurgery Distribution Share (2006-2007) 82
13.5 Radiosurgery, China, Company Share (2006-2007) 83
14 Medtronic, Inc. Company Profile 84
14.1 Company Overview 84
14.2 Value Chain Analysis 85
14.2.1 Manufacturing 85
14.2.2 Product Development 85
14.2.3 Sales and Marketing 86
14.3 Medtronic, Inc. Pipeline Products 87
14.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 87
14.3.2 Medtronic, Inc. Pipeline Products By Development Stage 89
14.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 91
14.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 93
14.3.5 Medtronic, Inc. Pipeline Products By News Summary 93
15 Boston Scientific Corporation Company Profile 95
15.1 Company Overview 95
15.2 Value Chain Analysis 95
15.2.1 Manufacturing 96
15.2.2 Product Development 96
15.2.3 Sales and Marketing 97
15.3 Boston Scientific Corporation Pipeline Products 98
15.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type 98
15.3.2 Boston Scientific Corporation Pipeline Products By Development Stage 99
15.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area 100
15.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials 101
15.3.5 Boston Scientific Corporation Pipeline Products By News Summary 102
16 Cordis Corporation Company Profile 104
16.1 Company Overview 104
16.2 Cordis Corporation Pipeline Products 104
16.2.1 Cordis Corporation Pipeline Products By Equipment Type 104
16.2.2 Cordis Corporation Pipeline Products By Development Stage 104
16.2.3 Cordis Corporation Pipeline Products By Therapy Area 105
16.2.4 Cordis Corporation Pipeline Products By Clinical Trials 105
16.2.5 Cordis Corporation Pipeline Products By News Summary 105
17 Elekta AB Company Profile 106
17.1 Company Overview 106
17.2 Value Chain Analysis 106
17.2.1 Manufacturing 107
17.2.2 Product Development 107
17.2.3 Sales and Marketing 107
17.3 Elekta AB Pipeline Products 108
17.3.1 Elekta AB Pipeline Products By Equipment Type 108
17.3.2 Elekta AB Pipeline Products By Development Stage 108
17.3.3 Elekta AB Pipeline Products By Therapy Area 108
17.3.4 Elekta AB Pipeline Products By News Summary 108
18 Accuray Incorporated Company Profile 109
18.1 Company Overview 109
18.2 Value Chain Analysis 109
18.2.1 Manufacturing 110
18.2.2 Product Development 110
18.2.3 Sales and Marketing 111
19 Cyberonics, Inc. Company Profile 112
19.1 Company Overview 112
19.2 Cyberonics, Inc. Pipeline Products 112
19.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type 112
19.2.2 Cyberonics, Inc. Pipeline Products By Development Stage 112
19.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area 112
20 Appendix 113
20.1 Global Markets Direct Research Methodology 113
20.2 Coverage 114
20.3 Secondary Research 114
20.4 Primary Research 115
20.5 Models 115
20.6 Forecasts 116
20.7 Expert Panels 116
20.8 Currency Conversion 117
20.9 Contact Us 118
20.10 Disclaimer 118
Executive Summary
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in China, 2000 - 2005 18
Figure 2: Medical Equipment Registration Process in China, 2007 27
Figure 3: CCC Mark Certification Process in China, 2007 29
Figure 4: Neurology Devices Cross Country Comparison (2000-2012) 34
Figure 5: Neurology Devices, China, Overall Revenues ($ mn), 2000-2012 35
Figure 6: Neurology Devices, China, Portfolio Analysis, 2000-2012 36
Figure 7: Neurology Devices, China, Overall Revenues ($ mn), Historic, 2000-2007 37
Figure 8: Neurology Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012 38
Figure 9: Neurology Devices, China Company share (%), 2007 41
Figure 10: CSF Management, China, Revenue ($ mn) by Segment, Historic, 2000-2007 42
Figure 11: CSF Management, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 43
Figure 12: CSF Management, China, Overall Volume (Units), Historic, 2000-2007 44
Figure 13: CSF Management, China, Overall Volume (Units), Forecast, 2007-2012 45
Figure 14: CSF Management, China, Company Share (%), 2007 48
Figure 15: Interventional Neurology, China, Revenue ($ mn) by Segment, Historic, 2000-2007 49
Figure 16: Interventional Neurology, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 50
Figure 17: Embolic Systems, China, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 51
Figure 18: Embolic Systems, China, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 52
Figure 19: Navigational Systems, China, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 53
Figure 20: Navigational Systems, China, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 54
Figure 21: Interventional Neurology, China, Overall Volume (Units), Historic, 2000-2007 55
Figure 22: Interventional Neurology, China, Overall Volume (Units), Forecast, 2007-2012 56
Figure 23: Embolic Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2007 57
Figure 24: Embolic Systems, China, Volume (Units) by Sub-Segment, Forecast, 2007-2012 58
Figure 25: Navigational Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2007 59
Figure 26: Navigational Systems, China, Volume (Units) by Sub-Segment, Forecast, 2007-2012 60
Figure 27: Interventional Neurology, China, Company Share (%), 2007 63
Figure 28: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2007 64
Figure 29: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 65
Figure 30: Neurostimulation Devices, China, Overall Volume (Units), Historic, 2000-2007 66
Figure 31: Neurostimulation Devices, China, Overall Volume (Units), Forecast, 2007-2012 67
Figure 32: Neurostimulation Devices, China, Company Share (%), 2007 70
Figure 33: Neurosurgical Products (Neuroendoscopes), China, Revenue ($ mn), Historic, 2000-2007 71
Figure 34: Neurosurgical Products (Neuroendoscopes), China, Revenue ($ mn), Forecast, 2007-2012 72
Figure 35: Neurosurgical Products (Neuroendoscopes), China, Overall Volume (Units), Historic, 2000-2007 73
Figure 36: Neurosurgical Products (Neuroendoscopes), China, Overall Volume (Units), Forecast, 2007-2012 74
Figure 37: Neurosurgical Products (Neuroendoscopes), China, Company Share (%), 2007 76
Figure 38: Radiosurgery, China, Revenue ($ mn) by Segment, Historic, 2000-2007 77
Figure 39: Radiosurgery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 78
Figure 40: Radiosurgery, China, Overall Volume (Units), Historic, 2000-2007 79
Figure 41: Radiosurgery, China, Overall Volume (Units), Forecast, 2007-2012 80
Figure 42: Radiosurgery, China, Company Share (%), 2007 83
Figure 43: Medtronic, Inc. Value Chain Analysis 85
Figure 44: Boston Scientific Corporation Value Chain Analysis 95
Figure 45: Elekta AB Value Chain Analysis 106
Figure 46: Accuray Incorporated Value Chain Analysis 109
Figure 47: Global Markets Direct Methodology 113
Customers who bought this item also bought
China Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
China Medical Equipment Market Analysis and Forecasts to 2015
Global Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Global Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Europe Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Asia Pacific Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Asia-Pacific Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Belgium Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Italy Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Netherlands Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Spain Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
Republic of Korea Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
|
|
|
|
